Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M57.2Revenue $M0.5Net Margin (%)-5,098.8Z-Score-3.8
Enterprise Value $M30.0EPS $-1.4Operating Margin %-4,943.0F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-5,098.8Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %-12.3Quick Ratio3.7Cash flow > EarningsY
Price/Sales71.65-y EBITDA Growth Rate %-37.2Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-39.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-67.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M20.0ROI % (ttm)-69.0Gross Margin Increase y-yN

Gurus Latest Trades with CLSN

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CLSN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CLSN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
EGWU, Inc. fka EGEN, Inc.10% Owner 2015-02-20Sell199,765$3.3-4.55 view
Fritz Frederick J.Director 2014-12-18Buy4,000$2.3434.62 view
Hooper Robert WDirector 2014-11-13Buy4,000$2.526 view
Tardugno Michael HCEO 2014-08-15Buy4,000$3.120.96 view
Tardugno Michael HCEO 2014-08-15Buy4,000$3.120.96 view
Martinez Alberto R JrDirector 2014-08-15Buy5,000$3.120.96 view
Fritz Frederick J.Director 2014-08-14Buy4,000$3.2-1.56 view
Martinez Alberto R JrDirector 2014-06-26Buy5,000$3.36-6.25 view
EGWU, Inc. fka EGEN, Inc.10% Owner 2014-06-20Sell0$0-6.25 view
Fritz Frederick J.Director 2014-06-11Buy5,000$3.2-1.56 view

Press Releases about CLSN :

    Quarterly/Annual Reports about CLSN:

    News about CLSN:

    Articles On GuruFocus.com
    Dead Biotech Plays Surge To Life May 07 2013 
    Celsion Corp. (CLSN) CEO Michael H Tardugno buys 6,000 Shares Nov 19 2009 
    Celsion Corp. (CLSN) CEO Michael H Tardugno buys 5,000 Shares Aug 17 2009 
    Celsion Reports Second Quarter 2009 Financial Results and Business Update Aug 05 2009 
    Celsion to Hold Second Quarter 2009 Financial Results Jul 31 2009 
    Celsion Corp. (CLSN) CEO Michael H Tardugno buys 3,750 Shares Mar 18 2009 
    Celsion Corporation to Hold Conference Call to Discuss Its Announced Japan License Agreement for The Dec 16 2008 
    Celsion Corporation Announces Exclusive Japan License Agreement with Yakult Honsha for ThermoDox® Dec 15 2008 

    More From Other Websites
    Nasdaq stocks posting largest volume increases Apr 15 2015
    Nasdaq stocks posting largest volume increases Apr 15 2015
    Celsion Announces Positive Interim Data from its Phase 2 DIGNITY Study in Breast Cancer Apr 15 2015
    8:04 am Celsion announces positive interim data from its Phase 2 DIGNITY study in breast cancer;... Apr 15 2015
    Celsion Announces Positive Interim Data from its Phase 2 DIGNITY Study in Breast Cancer Apr 15 2015
    Celsion Corporation Reports Year End 2014 Financial Results and Provides Business Update Mar 19 2015
    CELSION CORP Financials Mar 18 2015
    CELSION CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 12 2015
    Celsion Corporation Reports Year End 2014 Financial Results and Provides Business Update Mar 12 2015
    Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox® in Primary Liver... Mar 10 2015
    Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12,... Mar 05 2015
    Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox® in Primary Liver... Feb 23 2015
    UPDATE: Celsion Slightly Falls Back Following Treatment News Feb 20 2015
    Celsion Jumps On Interim Data On Cancer Drug Feb 20 2015
    Celsion Corporation Presents Clinical and Preclinical Data for GEN-1 IL-12 Immunotherapy in Ovarian... Feb 20 2015
    Celsion Corporation Presents Clinical and Preclinical Data for GEN-1 IL-12 Immunotherapy in Ovarian... Feb 20 2015
    CELSION CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD... Jan 20 2015
    Celsion Corporation and myTomorrows Partner to Introduce ThermoDox® Early Access Program in Europe... Jan 20 2015
    Celsion Corporation and myTomorrows Partner to Introduce ThermoDox® Early Access Program in Europe... Jan 20 2015
    Celsion Corporation Submits DNA-based Immunotherapy Clinical Protocol to the FDA as Part of a First... Jan 06 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK